Trial Profile
The effect of exenatide compared to lantus insulin on vascular function before and after a meal tolerance test in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 02 Oct 2009 Results from this study were published as an abstract in the proceedings of the 45th Annual Meeting of the European Association for the Study of Diabetes, 29 Sep 2009.